$ACOR Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACORDA THERAPEUTICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ACORDA THERAPEUTICS INC. Get notifications about new insider transactions in ACORDA THERAPEUTICS INC for free.
Page: < prev 1 2 3 4 5 6 ... 17 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 29 2018 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Option Exercise | A | 28.15 | 15,000 | 422,250 | 15,000 | |
| Jun 29 2018 | ACOR | ACORDA THERAPEUTIC ... | Kelley John P | Director | Option Exercise | A | 28.15 | 15,000 | 422,250 | 15,000 | |
| Jun 29 2018 | ACOR | ACORDA THERAPEUTIC ... | Jensen Peder | Director | Option Exercise | A | 28.15 | 15,000 | 422,250 | 15,000 | |
| Jun 29 2018 | ACOR | ACORDA THERAPEUTIC ... | Greene Barry E | Director | Option Exercise | A | 28.15 | 15,000 | 422,250 | 15,000 | |
| Jun 25 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 30.53 | 60,295 | 1,840,650 | 7,636,566 | 7.7 M to 7.6 M (-0.78 %) |
| Jun 20 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 30.37 | 58,700 | 1,782,596 | 7,696,861 | 7.8 M to 7.7 M (-0.76 %) |
| Jun 20 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 30.63 | 91,070 | 2,789,092 | 7,755,561 | 7.8 M to 7.8 M (-1.16 %) |
| Jun 20 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 30.77 | 243,414 | 7,490,920 | 7,846,631 | 8.1 M to 7.8 M (-3.01 %) |
| Jun 19 2018 | ACOR | ACORDA THERAPEUTIC ... | SMITH IAN F | Director | Option Exercise | M | 13.80 | 15,000 | 207,000 | 0 | |
| Jun 19 2018 | ACOR | ACORDA THERAPEUTIC ... | SMITH IAN F | Director | Option Exercise | M | 25.45 | 10,000 | 254,500 | 0 | |
| Jun 19 2018 | ACOR | ACORDA THERAPEUTIC ... | SMITH IAN F | Director | Sell | S | 31.42 | 25,000 | 785,568 | 0 | 25 K to 0 (-100.00 %) |
| Jun 19 2018 | ACOR | ACORDA THERAPEUTIC ... | SMITH IAN F | Director | Buy | M | 13.80 | 15,000 | 207,000 | 25,000 | 10 K to 25 K (+150.00 %) |
| Jun 19 2018 | ACOR | ACORDA THERAPEUTIC ... | SMITH IAN F | Director | Buy | M | 25.45 | 10,000 | 254,500 | 10,000 | 0 to 10 K |
| Jun 15 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 31.50 | 29,114 | 917,117 | 8,090,045 | 8.1 M to 8.1 M (-0.36 %) |
| Jun 15 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 31.54 | 87,796 | 2,769,279 | 8,119,159 | 8.2 M to 8.1 M (-1.07 %) |
| Jun 15 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 31.71 | 100,000 | 3,171,260 | 8,206,955 | 8.3 M to 8.2 M (-1.20 %) |
| Jun 15 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 31.50 | 29,114 | 917,117 | 8,090,045 | 8.1 M to 8.1 M (-0.36 %) |
| Jun 15 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 31.54 | 87,796 | 2,769,279 | 8,119,159 | 8.2 M to 8.1 M (-1.07 %) |
| Jun 15 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 31.71 | 100,000 | 3,171,260 | 8,206,955 | 8.3 M to 8.2 M (-1.20 %) |
| Jun 13 2018 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief, Bus. Ops & P ... | Sell | S | 32.68 | 300 | 9,805 | 4,693 | 5 K to 4.7 K (-6.01 %) |
| Jun 13 2018 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief, Bus. Ops & P ... | Sell | S | 31.65 | 3,131 | 99,099 | 4,993 | 8.1 K to 5 K (-38.54 %) |
| Jun 12 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 31.58 | 53,600 | 1,692,656 | 8,306,955 | 8.4 M to 8.3 M (-0.64 %) |
| Jun 12 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 31.58 | 53,600 | 1,692,656 | 8,306,955 | 8.4 M to 8.3 M (-0.64 %) |
| Jun 12 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 31.13 | 114,173 | 3,553,806 | 8,360,555 | 8.5 M to 8.4 M (-1.35 %) |
| Jun 12 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 31.13 | 114,173 | 3,553,806 | 8,360,555 | 8.5 M to 8.4 M (-1.35 %) |
| Jun 12 2018 | ACOR | ACORDA THERAPEUTIC ... | Sabella Lauren M | Chief Commercial Of ... | Option Exercise | M | 16.50 | 24,375 | 402,188 | 40,625 | |
| Jun 12 2018 | ACOR | ACORDA THERAPEUTIC ... | Sabella Lauren M | Chief Commercial Of ... | Sell | S | 35.00 | 24,375 | 853,125 | 11,165 | 35.5 K to 11.2 K (-68.58 %) |
| Jun 12 2018 | ACOR | ACORDA THERAPEUTIC ... | Sabella Lauren M | Chief Commercial Of ... | Buy | M | 16.50 | 24,375 | 402,188 | 35,540 | 11.2 K to 35.5 K (+218.32 %) |
| Jun 11 2018 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief, Bus. Ops & P ... | Option Exercise | M | 20.59 | 5,120 | 105,421 | 0 | |
| Jun 11 2018 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief, Bus. Ops & P ... | Option Exercise | M | 20.59 | 19,880 | 409,329 | 5,120 | |
| Jun 11 2018 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief, Bus. Ops & P ... | Sell | S | 33.10 | 20 | 662 | 8,124 | 8.1 K to 8.1 K (-0.25 %) |
| Jun 11 2018 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief, Bus. Ops & P ... | Sell | S | 31.90 | 200 | 6,380 | 8,144 | 8.3 K to 8.1 K (-2.40 %) |
| Jun 11 2018 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief, Bus. Ops & P ... | Sell | S | 30.58 | 500 | 15,290 | 8,344 | 8.8 K to 8.3 K (-5.65 %) |
| Jun 11 2018 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief, Bus. Ops & P ... | Sell | S | 29.61 | 400 | 11,845 | 8,844 | 9.2 K to 8.8 K (-4.33 %) |
| Jun 11 2018 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief, Bus. Ops & P ... | Sell | S | 28.41 | 4,000 | 113,630 | 9,244 | 13.2 K to 9.2 K (-30.20 %) |
| Jun 11 2018 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief, Bus. Ops & P ... | Buy | M | 20.59 | 5,120 | 105,421 | 13,244 | 8.1 K to 13.2 K (+63.02 %) |
| Jun 11 2018 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief, Bus. Ops & P ... | Sell | S | 28.02 | 19,880 | 556,976 | 8,124 | 28 K to 8.1 K (-70.99 %) |
| Jun 11 2018 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief, Bus. Ops & P ... | Buy | M | 20.59 | 19,880 | 409,329 | 28,004 | 8.1 K to 28 K (+244.71 %) |
| May 30 2018 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Offi ... | Sell | S | 24.26 | 42,615 | 1,034,006 | 4,503 | 47.1 K to 4.5 K (-90.44 %) |
| May 23 2018 | ACOR | ACORDA THERAPEUTIC ... | Greene Barry E | Director | Option Exercise | M | 20.16 | 10,000 | 201,600 | 0 | |
| May 23 2018 | ACOR | ACORDA THERAPEUTIC ... | Greene Barry E | Director | Payment of Exercise | F | 23.10 | 8,727 | 201,594 | 1,273 | 10 K to 1.3 K (-87.27 %) |
| May 23 2018 | ACOR | ACORDA THERAPEUTIC ... | Greene Barry E | Director | Buy | M | 20.16 | 10,000 | 201,600 | 10,000 | 0 to 10 K |
| May 22 2018 | ACOR | ACORDA THERAPEUTIC ... | Sabella Lauren M | Chief Commercial Of ... | Sell | S | 23.67 | 7,288 | 172,471 | 11,165 | 18.5 K to 11.2 K (-39.49 %) |
| May 22 2018 | ACOR | ACORDA THERAPEUTIC ... | BLANK BURKHARD | Chief Medical Offic ... | Option Exercise | M | 16.50 | 25,000 | 412,500 | 25,000 | |
| May 22 2018 | ACOR | ACORDA THERAPEUTIC ... | BLANK BURKHARD | Chief Medical Offic ... | Sell | S | 23.66 | 25,000 | 591,588 | 33,150 | 58.2 K to 33.2 K (-42.99 %) |
| May 22 2018 | ACOR | ACORDA THERAPEUTIC ... | BLANK BURKHARD | Chief Medical Offic ... | Buy | M | 16.50 | 25,000 | 412,500 | 58,150 | 33.2 K to 58.2 K (+75.41 %) |
| May 17 2018 | ACOR | ACORDA THERAPEUTIC ... | RAUSCHER STEVEN M | Director | Option Exercise | M | 20.16 | 10,000 | 201,600 | 0 | |
| May 17 2018 | ACOR | ACORDA THERAPEUTIC ... | RAUSCHER STEVEN M | Director | Sell | S | 24.59 | 10,000 | 245,853 | 0 | 10 K to 0 (-100.00 %) |
| May 17 2018 | ACOR | ACORDA THERAPEUTIC ... | RAUSCHER STEVEN M | Director | Buy | M | 20.16 | 10,000 | 201,600 | 10,000 | 0 to 10 K |
| May 15 2018 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Offi ... | Payment of Exercise | F | 24.35 | 3,930 | 95,696 | 47,118 | 51 K to 47.1 K (-7.70 %) |
| May 15 2018 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Offi ... | Payment of Exercise | F | 24.35 | 3,930 | 95,696 | 47,118 | 51 K to 47.1 K (-7.70 %) |
| May 04 2018 | ACOR | ACORDA THERAPEUTIC ... | SMITH IAN F | Director | Option Exercise | M | 20.16 | 10,000 | 201,600 | 0 | |
| May 04 2018 | ACOR | ACORDA THERAPEUTIC ... | SMITH IAN F | Director | Sell | S | 23.86 | 6,323 | 150,897 | 0 | 6.3 K to 0 (-100.00 %) |
| May 04 2018 | ACOR | ACORDA THERAPEUTIC ... | SMITH IAN F | Director | Sell | S | 23.46 | 3,677 | 86,277 | 6,323 | 10 K to 6.3 K (-36.77 %) |
| May 04 2018 | ACOR | ACORDA THERAPEUTIC ... | SMITH IAN F | Director | Buy | M | 20.16 | 10,000 | 201,600 | 10,000 | 0 to 10 K |
| Mar 12 2018 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Payment of Exercise | F | 25.65 | 2,470 | 63,356 | 106,809 | 109.3 K to 106.8 K (-2.26 %) |
| Mar 12 2018 | ACOR | ACORDA THERAPEUTIC ... | Sabella Lauren M | Chief Commercial Of ... | Payment of Exercise | F | 25.65 | 2,085 | 53,480 | 18,453 | 20.5 K to 18.5 K (-10.15 %) |
| Mar 12 2018 | ACOR | ACORDA THERAPEUTIC ... | Sabella Lauren M | Chief Commercial Of ... | Payment of Exercise | F | 25.65 | 2,085 | 53,480 | 18,453 | 20.5 K to 18.5 K (-10.15 %) |
| Mar 12 2018 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief, Bus. Ops & P ... | Payment of Exercise | F | 25.65 | 1,766 | 45,298 | 8,124 | 9.9 K to 8.1 K (-17.86 %) |
| Mar 08 2018 | ACOR | ACORDA THERAPEUTIC ... | Randall Lorin | Director | Option Exercise | M | 20.16 | 10,000 | 201,600 | 0 | |
| Mar 08 2018 | ACOR | ACORDA THERAPEUTIC ... | Randall Lorin | Director | Payment of Exercise | F | 24.90 | 8,096 | 201,590 | 1,904 | 10 K to 1.9 K (-80.96 %) |
| Mar 08 2018 | ACOR | ACORDA THERAPEUTIC ... | Randall Lorin | Director | Buy | M | 20.16 | 10,000 | 201,600 | 10,000 | 0 to 10 K |
| Mar 07 2018 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Option Exercise | M | 19.81 | 2,980 | 59,034 | 0 | |
| Mar 07 2018 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Payment of Exercise | F | 25.95 | 2,274 | 59,010 | 109,279 | 111.6 K to 109.3 K (-2.04 %) |
| Mar 07 2018 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Buy | M | 19.81 | 2,980 | 59,034 | 111,553 | 108.6 K to 111.6 K (+2.74 %) |
| Mar 07 2018 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | M | 19.81 | 62,500 | 1,238,125 | 0 | |
| Mar 07 2018 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Payment of Exercise | F | 25.95 | 24,590 | 638,111 | 564,285 | 588.9 K to 564.3 K (-4.18 %) |
| Mar 07 2018 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Buy | M | 19.81 | 62,500 | 1,238,125 | 588,875 | 526.4 K to 588.9 K (+11.87 %) |
| Feb 26 2018 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Grant | A | 0.00 | 6,463 | 0 | 108,573 | 102.1 K to 108.6 K (+6.33 %) |
| Feb 26 2018 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief, Bus. Ops & P ... | Grant | A | 0.00 | 5,197 | 0 | 9,890 | 4.7 K to 9.9 K (+110.74 %) |
| Feb 26 2018 | ACOR | ACORDA THERAPEUTIC ... | Sabella Lauren M | Chief Commercial Of ... | Grant | A | 0.00 | 5,859 | 0 | 20,538 | 14.7 K to 20.5 K (+39.91 %) |
| Feb 26 2018 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Dev. ... | Grant | A | 0.00 | 5,742 | 0 | 51,048 | 45.3 K to 51 K (+12.67 %) |
| Feb 26 2018 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Grant | A | 0.00 | 14,727 | 0 | 526,375 | 511.6 K to 526.4 K (+2.88 %) |
| Feb 26 2018 | ACOR | ACORDA THERAPEUTIC ... | Batycky Richard P. | Chief Tech. Off. & ... | Grant | A | 0.00 | 5,197 | 0 | 55,513 | 50.3 K to 55.5 K (+10.33 %) |
| Feb 21 2018 | ACOR | ACORDA THERAPEUTIC ... | STRADER CATHERINE D. | Director | Option Exercise | A | 25.80 | 4,974 | 128,329 | 4,974 | |
| Jan 23 2018 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Option Exercise | M | 19.81 | 34,520 | 683,841 | 2,980 | |
| Jan 23 2018 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Sell | S | 28.63 | 350 | 10,020 | 102,110 | 102.5 K to 102.1 K (-0.34 %) |
| Jan 23 2018 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Sell | S | 27.58 | 34,170 | 942,299 | 102,460 | 136.6 K to 102.5 K (-25.01 %) |
| Jan 23 2018 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Buy | M | 19.81 | 34,520 | 683,841 | 136,630 | 102.1 K to 136.6 K (+33.81 %) |
| Jan 22 2018 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief, Bus. Ops & P ... | Option Exercise | M | 19.81 | 30,418 | 602,581 | 0 | |
| Jan 22 2018 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief, Bus. Ops & P ... | Option Exercise | M | 19.81 | 582 | 11,529 | 30,418 | |
| Jan 22 2018 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief, Bus. Ops & P ... | Sell | S | 28.38 | 500 | 14,190 | 4,693 | 5.2 K to 4.7 K (-9.63 %) |
| Jan 22 2018 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief, Bus. Ops & P ... | Sell | S | 27.58 | 29,918 | 825,007 | 5,193 | 35.1 K to 5.2 K (-85.21 %) |
| Jan 22 2018 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief, Bus. Ops & P ... | Buy | M | 19.81 | 30,418 | 602,581 | 35,111 | 4.7 K to 35.1 K (+648.16 %) |
| Jan 22 2018 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief, Bus. Ops & P ... | Sell | S | 27.00 | 582 | 15,714 | 4,693 | 5.3 K to 4.7 K (-11.03 %) |
| Jan 22 2018 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief, Bus. Ops & P ... | Buy | M | 19.81 | 582 | 11,529 | 5,275 | 4.7 K to 5.3 K (+12.40 %) |
| Dec 05 2017 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Sell | S | 20.52 | 4,564 | 93,662 | 102,110 | 106.7 K to 102.1 K (-4.28 %) |
| Dec 05 2017 | ACOR | ACORDA THERAPEUTIC ... | Sabella Lauren M | Chief Commercial Of ... | Sell | S | 20.53 | 1,670 | 34,289 | 14,679 | 16.3 K to 14.7 K (-10.21 %) |
| Dec 05 2017 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief, Bus. Ops & P ... | Sell | S | 20.51 | 3,993 | 81,885 | 4,693 | 8.7 K to 4.7 K (-45.97 %) |
| Dec 05 2017 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Dev. ... | Sell | S | 20.54 | 817 | 16,784 | 45,306 | 46.1 K to 45.3 K (-1.77 %) |
| Dec 05 2017 | ACOR | ACORDA THERAPEUTIC ... | BLANK BURKHARD | Chief Medical Offic ... | Sell | S | 20.53 | 11,050 | 226,893 | 33,150 | 44.2 K to 33.2 K (-25.00 %) |
| Oct 11 2017 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief, Bus. Ops & P ... | Sell | S | 25.40 | 250 | 6,350 | 8,686 | 8.9 K to 8.7 K (-2.80 %) |
| Aug 31 2017 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Buy | P | 19.62 | 116,201 | 2,280,119 | 8,474,728 | 8.4 M to 8.5 M (+1.39 %) |
| Aug 31 2017 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Buy | P | 19.52 | 150,000 | 2,927,280 | 8,358,527 | 8.2 M to 8.4 M (+1.83 %) |
| Aug 31 2017 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Buy | P | 19.05 | 500,000 | 9,523,050 | 8,208,527 | 7.7 M to 8.2 M (+6.49 %) |
| Aug 03 2017 | ACOR | ACORDA THERAPEUTIC ... | RAUSCHER STEVEN M | Director | Option Exercise | M | 18.21 | 10,000 | 182,100 | 0 | |
| Aug 03 2017 | ACOR | ACORDA THERAPEUTIC ... | RAUSCHER STEVEN M | Director | Sell | S | 21.57 | 10,000 | 215,703 | 0 | 10 K to 0 (-100.00 %) |
| Aug 03 2017 | ACOR | ACORDA THERAPEUTIC ... | RAUSCHER STEVEN M | Director | Buy | M | 18.21 | 10,000 | 182,100 | 10,000 | 0 to 10 K |
| Aug 03 2017 | ACOR | ACORDA THERAPEUTIC ... | Greene Barry E | Director | Option Exercise | M | 18.21 | 10,000 | 182,100 | 0 | |
| Aug 03 2017 | ACOR | ACORDA THERAPEUTIC ... | Greene Barry E | Director | Sell | S | 21.57 | 10,000 | 215,697 | 0 | 10 K to 0 (-100.00 %) |
| Aug 03 2017 | ACOR | ACORDA THERAPEUTIC ... | Greene Barry E | Director | Buy | M | 18.21 | 10,000 | 182,100 | 10,000 | 0 to 10 K |
| Jun 20 2017 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Buy | P | 16.95 | 20,000 | 338,998 | 511,648 | 491.6 K to 511.6 K (+4.07 %) |
| Jun 02 2017 | ACOR | ACORDA THERAPEUTIC ... | Jensen Peder | Director | Option Exercise | A | 13.80 | 15,000 | 207,000 | 15,000 | |
| Jun 02 2017 | ACOR | ACORDA THERAPEUTIC ... | Greene Barry E | Director | Option Exercise | A | 13.80 | 15,000 | 207,000 | 15,000 | |
| Jun 02 2017 | ACOR | ACORDA THERAPEUTIC ... | SMITH IAN F | Director | Option Exercise | A | 13.80 | 15,000 | 207,000 | 15,000 | |
| Jun 02 2017 | ACOR | ACORDA THERAPEUTIC ... | RAUSCHER STEVEN M | Director | Option Exercise | A | 13.80 | 15,000 | 207,000 | 15,000 | |
| Jun 02 2017 | ACOR | ACORDA THERAPEUTIC ... | Randall Lorin | Director | Option Exercise | A | 13.80 | 15,000 | 207,000 | 15,000 | |
| Jun 02 2017 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Option Exercise | A | 13.80 | 15,000 | 207,000 | 15,000 | |
| Jun 02 2017 | ACOR | ACORDA THERAPEUTIC ... | Kelley John P | Director | Option Exercise | A | 13.80 | 15,000 | 207,000 | 15,000 | |
| May 17 2017 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Dev. ... | Sell | S | 15.75 | 7,704 | 121,319 | 46,123 | 53.8 K to 46.1 K (-14.31 %) |
| May 03 2017 | ACOR | ACORDA THERAPEUTIC ... | Sabella Lauren M | Chief Commercial Of ... | Option Exercise | A | 16.50 | 65,000 | 1,072,500 | 65,000 | |
| May 03 2017 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Dev. ... | Option Exercise | A | 16.50 | 65,000 | 1,072,500 | 65,000 | |
| May 03 2017 | ACOR | ACORDA THERAPEUTIC ... | BLANK BURKHARD | Chief Medical Offic ... | Option Exercise | A | 16.50 | 50,000 | 825,000 | 50,000 | |
| Mar 03 2017 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Option Exercise | A | 27.48 | 12,500 | 343,438 | 12,500 | |
| Mar 03 2017 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Grant | A | 0.00 | 5,000 | 0 | 106,674 | 101.7 K to 106.7 K (+4.92 %) |
| Mar 03 2017 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Dev. ... | Option Exercise | A | 27.48 | 11,500 | 315,963 | 11,500 | |
| Mar 03 2017 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Dev. ... | Grant | A | 0.00 | 4,600 | 0 | 53,827 | 49.2 K to 53.8 K (+9.34 %) |
| Mar 03 2017 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Option Exercise | A | 27.48 | 5,090 | 139,848 | 5,090 | |
| Mar 03 2017 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Grant | A | 0.00 | 2,036 | 0 | 78,594 | 76.6 K to 78.6 K (+2.66 %) |
| Mar 03 2017 | ACOR | ACORDA THERAPEUTIC ... | BLANK BURKHARD | Chief Medical Offic ... | Option Exercise | A | 27.48 | 10,500 | 288,488 | 10,500 | |
| Mar 03 2017 | ACOR | ACORDA THERAPEUTIC ... | BLANK BURKHARD | Chief Medical Offic ... | Grant | A | 0.00 | 4,200 | 0 | 44,200 | 40 K to 44.2 K (+10.50 %) |
| Feb 22 2017 | ACOR | ACORDA THERAPEUTIC ... | STRADER CATHERINE D. | Director | Option Exercise | A | 25.30 | 25,000 | 632,500 | 25,000 | |
| Feb 13 2017 | ACOR | ACORDA THERAPEUTIC ... | Greene Barry E | Director | Option Exercise | M | 22.13 | 723 | 16,000 | 0 | |
| Feb 13 2017 | ACOR | ACORDA THERAPEUTIC ... | Greene Barry E | Director | Sell | S | 22.65 | 723 | 16,376 | 0 | 723 to 0 (-100.00 %) |
| Feb 13 2017 | ACOR | ACORDA THERAPEUTIC ... | Greene Barry E | Director | Buy | M | 22.13 | 723 | 16,000 | 723 | 0 to 723 |
| Feb 13 2017 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Option Exercise | M | 22.13 | 67,586 | 1,495,678 | 0 | |
| Feb 13 2017 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 22.41 | 67,586 | 1,514,379 | 76,558 | 144.1 K to 76.6 K (-46.89 %) |
| Feb 13 2017 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Buy | M | 22.13 | 67,586 | 1,495,678 | 144,144 | 76.6 K to 144.1 K (+88.28 %) |
| Jan 05 2017 | ACOR | ACORDA THERAPEUTIC ... | Greene Barry E | Director | Option Exercise | M | 15.91 | 3,017 | 48,000 | 0 | |
| Jan 05 2017 | ACOR | ACORDA THERAPEUTIC ... | Greene Barry E | Director | Sell | S | 19.26 | 3,017 | 58,113 | 0 | 3 K to 0 (-100.00 %) |
| Jan 05 2017 | ACOR | ACORDA THERAPEUTIC ... | Greene Barry E | Director | Buy | M | 15.91 | 3,017 | 48,000 | 3,017 | 0 to 3 K |
| Dec 16 2016 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | M | 15.49 | 40,172 | 622,264 | 0 | |
| Dec 16 2016 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 21.35 | 408 | 8,711 | 479,688 | 480.1 K to 479.7 K (-0.08 %) |
| Dec 16 2016 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 20.75 | 39,764 | 824,944 | 480,096 | 519.9 K to 480.1 K (-7.65 %) |
| Dec 16 2016 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Buy | M | 15.49 | 40,172 | 622,264 | 519,860 | 479.7 K to 519.9 K (+8.37 %) |
| Dec 05 2016 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Sell | S | 21.30 | 100 | 2,130 | 101,674 | 101.8 K to 101.7 K (-0.10 %) |
| Dec 05 2016 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Sell | S | 20.72 | 3,247 | 67,270 | 101,774 | 105 K to 101.8 K (-3.09 %) |
| Dec 05 2016 | ACOR | ACORDA THERAPEUTIC ... | Sabella Lauren M | Chief Commercial Of ... | Sell | S | 20.74 | 2,429 | 50,381 | 11,949 | 14.4 K to 11.9 K (-16.89 %) |
| Dec 05 2016 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief, Bus. Ops & P ... | Sell | S | 20.74 | 4,416 | 91,594 | 4,536 | 9 K to 4.5 K (-49.33 %) |
| Dec 05 2016 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Dev. ... | Sell | S | 20.72 | 443 | 9,180 | 49,227 | 49.7 K to 49.2 K (-0.89 %) |
| Dec 05 2016 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 20.74 | 7,160 | 148,482 | 479,688 | 486.8 K to 479.7 K (-1.47 %) |
| Dec 05 2016 | ACOR | ACORDA THERAPEUTIC ... | BLANK BURKHARD | Chief Medical Offic ... | Sell | S | 20.74 | 10,000 | 207,442 | 40,000 | 50 K to 40 K (-20.00 %) |
| Dec 05 2016 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 20.76 | 4,855 | 100,774 | 76,558 | 81.4 K to 76.6 K (-5.96 %) |
| Oct 25 2016 | ACOR | ACORDA THERAPEUTIC ... | Batycky Richard P. | Chief Tech. Off. & ... | Sell | S | 20.30 | 2,063 | 41,877 | 45,916 | 48 K to 45.9 K (-4.30 %) |
| Oct 11 2016 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief, Bus. Ops & P ... | Sell | S | 20.82 | 250 | 5,205 | 8,952 | 9.2 K to 9 K (-2.72 %) |
| Oct 05 2016 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Sell | S | 20.78 | 3,750 | 77,927 | 105,021 | 108.8 K to 105 K (-3.45 %) |
| Sep 27 2016 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Option Exercise | M | 8.50 | 500 | 4,250 | 0 | |
| Sep 27 2016 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Sell | S | 27.32 | 500 | 13,660 | 108,771 | 109.3 K to 108.8 K (-0.46 %) |
| Sep 27 2016 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Buy | M | 8.50 | 500 | 4,250 | 109,271 | 108.8 K to 109.3 K (+0.46 %) |
| Aug 11 2016 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Option Exercise | M | 22.13 | 9,754 | 215,856 | 67,586 |